Eunjoo Kim
(Nubebe Korean Medical Clinic Bundang Center)
Young-Woo Lim (Nubebe Korean Medical Clinic Bundang Center) Ji-Myung Ok (Nubebe Korean Medical Clinic Gangnam Center) Seo-Young Kim (Nubebe Korean Medical Clinic Bundang Center) |
1 | Lee, D. (2016). An introduction to propensity score matching methods. Anesth Pain Med, 11, 130-148. DOI: https://doi.org/10.17085/apm.2016.11.2.130 DOI |
2 | Lee, H., Kim, Y., Park, I. (2013). Calculation of sample size in clinical trials. Clinics Shoulder Elbow, 16(1), 53-57. https://doi.org/10.5397/CiSE.2013.16.1.53 DOI |
3 | A handbook on clinical trial design and number of subjects. Department of Applied Statistics in National Institute of Toxicological Research. 2008 Oct[cited 2021. Dec 27];p.35. Available from: URL:https://www.mfds.go.kr/brd/m_218/view.do?eq=8573&srchFr=&srchTo=&srchWord=srchTp&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=64 |
4 | Pellegrini, D., Torlasco, C., Ochoa, J.E., Parati, G. (2020). Contribution of telemedicine and information technology to hypertension control. Hypertens Res, 43(7), 621-628. DOI: 10.1038/s41440-020-0422-4 DOI |
5 | World Health Organization, Telemedicine: opportunities and developments in member states. Report on the second global survey on eHealth., 2010 |
6 | Lee, J. (2020). The recent trends in telemedicine in the era of COVID-19 and policy recommendations for the balanced growth of healthcare service industry in Korea. JCCT, 6(4), 591-598. DOI :https://doi.org/10.17703/JCCT.2020.6.4.591 DOI |
7 | Baek, K. (2020). A study on telemedicine in the United States: focusing on implications for countermeasures about COVID-19. Kyungpook Natl. Univ. Law Journal, 70, 363-386. DOI :10.17248/knulaw..70.202007.363 DOI |
8 | Wall, K.C., Politzer, C.S., Chahla, J., Garrigues, G.E. (2020). Obesity is associated with an increased prevalence of glenohumeral osteoarthritis and arthroplasty: A cohort study. Orthop Clin N Am, 51(2), 259-264. DOI: 10.1016/j.ocl.2019.12.001 DOI |
9 | Kolb, R., Sutterwala, F.S., Zhang, W. (2016). Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol, 29, 77-89. DOI:10.1016/j.coph.2016.07.005 DOI |
10 | Zhou, Y., Chi, J., Lv, W., Wang, Y. (2021). Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev, 37(2), e3377. doi:10.1002/dmrr.3377. DOI |
11 | Yoon, N., Yoo, Y., Kim, M., Kim, S., Lim, Y., Lim, H., et al. (2018). Analysis of adverse events in weight loss program in combination with 'Gamitaeeumjowee-tang' and low-calorie diet. J Korean Med Obes Res, 18(1), 1-9. DOI: https://doi.org/10.15429/jkomor.2018.18.1.1 DOI |
12 | Won, S., Lee, M., Moon, S., Jung, H., Ki, J., Park, S., et al. (2021). The necessity of analyzing the effectiveness of temporary non-face-to-face treatment. 2021 Analysis of National Assembly Audit Issues, 9, 37-38. |
13 | Lee, A., Lee, D., Kim, M., Lee, H., Choi, K., Kim, S., et al. (2021). Gamitaeeumjowee-tang for weight loss in diabetic patients: A retrospective chart review. J Korean Med, 42(1), 46-58. DOI: https://doi.org/10.13048/jkm.21004 DOI |
14 | Kang, E., Park, Y., Kim, M., Park, Y. (2017). A Study on Factors Associated with Weight Loss by 'Gamitaeeumjowee-Tang'. J Korean Med Obes Res, 17(2), 68-72. DOI : https://doi.org/10.15429/jkomor.2017.17.2.68 DOI |
15 | Park, Y., Cominguez, D., Kim, H., Jin, J., Koh, D., Kim, S., et al. (2021). Therapeutic effects of Gambi-jung for the treatment of obesity. Biomed Pharmacother, 141, 111838. DOI: 10.1016/j.biopha.2021.111838 DOI |
16 | Lee, E., Park, Y., Lim, Y., Kim, S. (2020). The association between sleep and weight loss among adult women with obesity administered with Gamitaeeumjowee-tang. J Korean Med, 41(3), 22-31. DOI : https://doi.org/10.13048/jkm.20023 DOI |
17 | Korea Institute of Drug Safety & Risk Reaction Management. Adverse Drug Assessment Report. 1st ed. Seoul: Korea Institute of Drug Safety & Risk Management. 2013:60-3. |
18 | National Cancer Institute. National Institute of Health. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 2010. |
19 | Kim, E., Lim, Y., Park, Y., Kang, J., Kim, S. (2022). Prediction of initial average weight loss in overweight and obese people taking Gamitaeeumjowi-tang. Korean J Subhealth Med, 3(1), 13-22. DOI :https://doi.org/10.37928/kjsm.2022.3.1.13 DOI |
20 | Korea Institute of Drug Safety & Risk Management. Terminology Guide for Reporting Adverse Drug Reactions. Seoul: Korea Institute of Drug Safety & Risk Management. 2014:1-6. |
21 | Han, J., Park, Y. (2019). Analysis of Factors Influencing Obesity Treatment according to Initial Condition and Compliance with Medication. J Korean Med Obes Res, 19(1), 31-41. DOI : https://doi.org/10.15429/jkomor.2019.19.1.31 DOI |
22 | Choi, Y. (2020). A study on the introduction of telemedicine -Coronavirus disease 2019 and the need for the introduction of telemedicine-. International law review, 12(1), 113-137. DOI: 10.36727/jjilr.12.1.202005.005 DOI |
23 | Johnson, K.E., Alencar, M.K., Coakley, K.E., Swift, D.L., Cole, N.H., Mermier, C.M., et al. (2019). Telemedicine-based health coaching is effective for inducing weight loss and improving metabolic markers. Telemed J E Health, 25(2), 85-92. doi: 10.1089/tmj.2018.0002. DOI |
24 | Befort, C.A., VanWormer, J.J., Desouza, C., Ellerbeck, E.F., Gajewski, B., Kimminau, K.S., et al. (2021). Effect of behavioral therapy with in-clinic or telephone group visits vs in-clinic individual visits on weight loss among patients with obesity in rural clinical practice: A Randomized Clinical Trial. JAMA, 325(4), 363-372. DOI: 10.1001/jama.2020.25855 DOI |
25 | Jeong, J., Jeon, J., Bae, K., Choi, Y., Park, K., Kim, J., et al. (2018). Smart Care Based on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-Center Randomized Controlled Trial. Telemed J E Health, 24(8), 604-613. doi: 10.1089/tmj.2017.0203 DOI |
26 | Fleischman, A., Hourigan, S.E., Lyon, H.N., Landry, M.G., Reynolds, J., Steltz, S.K., et al. (2016). Creating an integrated care model for childhood obesity: a randomized pilot study utilizing telehealth in a community primary care setting. Clin Obes, 6(6), 380-388. doi:10.1111/cob.12166. DOI |
27 | Margolis, K.L., Asche, S.E., Bergdall, A.R., Dehmer, S.P., Groen, S.E., Kadrmas, H.M., et al. (2013). Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA, 310(1), 46-56. DOI:10.1001/jama.2013.6549 DOI |
28 | Donnelly, J.E., Goetz, J., Gibson, C., Sullivan, D.K., Lee, R., Smith, B.K., et al. (2013). Equivalent weight loss for weight management programs delivered by phone and clinic. Obesity (Silver Spring). 21(10), 1951-9. doi:10.1002/oby.20334. DOI |
29 | Hwang, M., Shin, H., Song, M. (2007). Literature review of herbal medicines on treatment of obesity since 2000;mainly about Ephedra Herba. J Korean Med Obes Res, 7(1), 39-54. |
30 | Perri, M.G., Shankar, M.N., Daniels, M.J., Durning, P.E., Ross, K.M., Limacher, M.C., et al. (2020). Effect of telehealth extended care for maintenance of weight loss in rural US communities: a randomized clinical trial. JAMANetwOpen, 3(6), e206764. doi: 10.1001/jamanetworkopen.2020.6764. DOI |
![]() |